Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1976-05-13
1978-07-25
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Lymphokine
424167, 424177, 424230, 424355, A61K 3178
Patent
active
041029950
ABSTRACT:
A tar formulation used in the treatment of skin disorders containing tar, propylene glycol, ethyl alcohol and a gelling agent e.g. Carbopol 940.
REFERENCES:
patent: 2602039 (1952-07-01), Wershaw
patent: 2622057 (1952-12-01), Augenblick
patent: 2798053 (1957-07-01), Brown
patent: 3043745 (1962-07-01), Singer
patent: 3061512 (1962-10-01), Anderson et al.
patent: 3071510 (1963-01-01), Wershaw et al.
patent: 3210251 (1965-10-01), King
patent: 3262851 (1966-07-01), Gottfried et al.
patent: 3472931 (1969-10-01), Stoughton
patent: 3485915 (1969-12-01), Gerstein et al.
patent: 3627871 (1971-12-01), Groves et al.
patent: 3749773 (1973-07-01), Ninger et al.
Lemberger, Handbook on Non-Prescription Drugs, (1973); pp. 161-166.
Lubowe, Ibid, pp. 167-171.
Holtzman Irving
Mugford David J.
Schenkman Leonard
Westwood Pharmaceuticals Inc.
LandOfFree
Tar gel formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tar gel formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tar gel formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1421697